Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids

3 May 2016

Abstract excerpt

Acute inflammatory demyelinating polyneuropathy (AIDP) - the main form of Guillain-Barre syndrome-is a rare and severe disorder of the peripheral nervous system with an unknown etiology. One of the hallmarks of the AIDP pathogenesis is a significantly elevated cerebrospinal fluid (CSF) protein level. In this paper CSF peptidome and proteome in AIDP were analyzed and compared with multiple sclerosis and control...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hereditary Neurological Disorders
Share to Myasthenia Gravis and Thymoma
Share to Peripheral Neuropathies and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27143409
DOI: 10.1074/mcp.m115.056036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological FluidsPMID 27143409Read ↗

Extensive cytokine biomarker analysis in serum of Guillain-Barré syndrome patientsSemantic proximity Read ↗

Longitudinal proteomics defines stage-specific molecular signatures in Guillain-Barré syndromeSemantic proximity Read ↗

Comparative proteomics of cerebrospinal fluid reveals a predictive model for differential diagnosis of pneumococcal, meningococcal, and enteroviral meningitis, and novel putative therapeutic targetsSemantic proximity Read ↗

The Brain Reacting to COVID-19: Analysis of the Cerebrospinal Fluid and Serum Proteome,Transcriptome and Inflammatory ProteinsSemantic proximity Read ↗

Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDPSemantic proximity Read ↗

Molecular markers in the CSF proteome differentiate neuroinflammatory diseasesSemantic proximity Read ↗

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Pathophysiology, Clinical Patterns, and Therapeutic Challenges of Intractable and Severe FormsSemantic proximity Read ↗

Cerebrospinal fluid proteome maps detect pathogen-specific host response patterns in meningitisSemantic proximity Read ↗

Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndromeSemantic proximity Read ↗

Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP).Semantic proximity Read ↗

Bioinformatics analysis of the potential biomarkers of Multiple Sclerosis and Guillain-Barré syndromeSemantic proximity Read ↗

CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical SubtypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.